Tapinarof - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for tapinarof and what is the scope of patent protection?

Tapinarof is the generic ingredient in one branded drug marketed by Dermavant Sci and is included in one NDA. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tapinarof has seventy-two patent family members in thirty-six countries.

One supplier is listed for this compound.

Summary for tapinarof

International Patents:	72
US Patents:	9
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	60
Clinical Trials:	13
Patent Applications:	211
What excipients (inactive ingredients) are in tapinarof?	tapinarof excipients list
DailyMed Link:	tapinarof at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for tapinarof

Generic Entry Date for tapinarof^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: ⤷ Sign Up Dosage: CREAM;TOPICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for tapinarof

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dermavant Sciences, Inc.	Phase 2/Phase 3
Wake Forest University Health Sciences	Phase 2/Phase 3
Psoriasis Treatment Center of Central New Jersey	Phase 4

See all tapinarof clinical trials

Pharmacology for tapinarof

Drug Class	Aryl Hydrocarbon Receptor Agonist
Mechanism of Action	Aryl Hydrocarbon Receptor Agonists

Anatomical Therapeutic Chemical (ATC) Classes for tapinarof

D05AX	Other antipsoriatics for topical use
D05A	ANTIPSORIATICS FOR TOPICAL USE
D05	ANTIPSORIATICS
D	Dermatologicals

US Patents and Regulatory Information for tapinarof

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dermavant Sci	VTAMA	tapinarof	CREAM;TOPICAL	215272-001	May 23, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dermavant Sci	VTAMA	tapinarof	CREAM;TOPICAL	215272-001	May 23, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y		⤷ Sign Up
Dermavant Sci	VTAMA	tapinarof	CREAM;TOPICAL	215272-001	May 23, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Dermavant Sci	VTAMA	tapinarof	CREAM;TOPICAL	215272-001	May 23, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Dermavant Sci	VTAMA	tapinarof	CREAM;TOPICAL	215272-001	May 23, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for tapinarof

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
China	114042041	局部药物组合物 (TOPICAL PHARMACEUTICAL COMPOSITIONS)	⤷ Sign Up
Mexico	2020004785	PROCESO PARA PREPARAR TAPINAROF. (PROCESS FOR PREPARING TAPINAROF.)	⤷ Sign Up
Dominican Republic	P2017000270	COMPOSICIONES FARMACÉUTICAS TÓPICAS	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2019094934		⤷ Sign Up
Eurasian Patent Organization	038624	ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ МЕСТНОГО ПРИМЕНЕНИЯ (TOPICAL PHARMACEUTICAL COMPOSITION)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.